CF Therapeutics Development Center

The Cystic Fibrosis Therapeutics Development Network (CF-TDN) was established by the Cystic Fibrosis Foundation as a network of highly specialized centers of excellence in clinical research. The network includes core laboratories, interpretation centers, and a coordinating center. This highly collaborative network works to develop and conduct early phase clinical trials involving new therapeutic agents for cystic fibrosis. Investigators at the CF-TDN sites are widely considered to be leaders in the field of CF research.

The Minnesota CF Center has been a member of the TDN as a research center since 2002. As such, the center has established a clinical research core exclusively dedicated to CF patients and with research programs and trained staff capable of conducting all phases of clinical trials. In addition, our program is capable of participating in complex studies involving inpatient stays, and performing specialized procedures required in the conduct of sophisticated early drug studies.

If you would like to learn more about our TDN program please contact Brooke Noren, RN at 612-625-7995 or by email at boer0039@umn.edu